Evidence map›Paper›PMID 35723227›Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2022

Novel roles of mTORC2 in regulation of insulin secretion by actin filament remodeling.

Manuel Blandino-Rosano, Joshua O Scheys, Joao Pedro Werneck-de-Castro, Ruy A Louzada, Joana Almaça, Gil Leibowitz, Markus A Rüegg, Michael N Hall, Ernesto Bernal-Mizrachi

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Sestrin2 in diabetes and diabetic complications.Frontiers in endocrinology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Manuel Blandino-RosanoDivision of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.ORCID 0000-0002-1712-8233
Joshua O ScheysMedical School, Division of Metabolism, Endocrinology, and Diabetes and Brehm Center for Diabetes Research, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
Joao Pedro Werneck-de-CastroDivision of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.ORCID 0000-0001-9242-7930
Ruy A LouzadaDivision of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.ORCID 0000-0003-1789-4234
Joana AlmaçaDivision of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.
Gil LeibowitzDiabetes Unit and Endocrine Service, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.ORCID 0000-0002-6915-4361
Markus A RüeggBiozentrum, University of Basel, Basel, Switzerland.ORCID 0000-0002-4974-9384
Michael N HallBiozentrum, University of Basel, Basel, Switzerland.ORCID 0000-0002-2998-0757
Ernesto Bernal-MizrachiDivision of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.ORCID 0000-0001-9997-3301
University of Miami · USUniversity of Basel · CHHadassah Medical Center · ILUniversity of Michigan · US

Funding

Postdoc Stipend Supplement: Developmental Origins of Metabolic Disorders T32T32DK071212 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVID P OLSON, Kanakadurga Singer · 2005 to 2026
$5.4M
AKT/mTOR Signaling and Regulation of Cell Cycle in beta CellsR01DK073716 · NIDDK · WASHINGTON UNIVERSITY · PI BERNAL-MIZRACHI, ERNESTO · 2006 to 2022
$4.6M
Nutrient Signals and Programming of Pancreas DevelopmentR01DK084236 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BERNAL-MIZRACHI, ERNESTO · 2010 to 2018
$2.9M
Amino acid sensing mechanisms in beta and alpha cellsR01DK133183 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Ernesto Bernal-Mizrachi · 2022 to 2026
$1.9M
mTOR signaling and regulation of alpha-cell mass and functionI01BX002728 · VA · MIAMI VA HEALTH CARE SYSTEM · PI BERNAL-MIZRACHI, ERNESTO · 2016 to 2025
–
BLRD VA I01 BX002728NIDDK NIH HHS R01 DK073716NIDDK NIH HHS R01 DK084236NIDDK NIH HHS R01 DK133183NIDDK NIH HHS T32 DK071212
6 · The paper itself

Abstract

Mammalian target of rapamycin (mTOR) kinase is an essential hub where nutrients and growth factors converge to control cellular metabolism. mTOR interacts with different accessory proteins to form complexes 1 and 2 (mTORC), and each complex has different intracellular targets. Although mTORC1's role in β-cells has been extensively studied, less is known about mTORC2's function in β-cells. Here, we show that mice with constitutive and inducible β-cell-specific deletion of RICTOR (

Indexed as

ActinsInsulinActin CytoskeletonAnimalsGlucagon-Like Peptide 1GlucoseInsulin SecretionMammalsMechanistic Target of Rapamycin Complex 2MiceTOR Serine-Threonine KinasesActinsGlucagon-Like Peptide 1GlucoseInsulinMechanistic Target of Rapamycin Complex 2TOR Serine-Threonine Kinasesactin remodelingGLP-1insulin secretionmTORC2RICTOR

Identifiers

PMID35723227
PMCPMC9291412
OpenAlexW4283170170

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.